|
|
|
Research Papers
Howard Hughes Medical Institute, Kaplan Cancer Center, New York, New York.
Abstract
In Ras cotransformation assays, Max exhibited a biphasic effect on Myc transformation activity. Cotransfection of low levels of Max expression plasmid stimulated Myc transformation activity, but cotransfection of high levels suppressed it. Mutations in the functionally undefined Max amino- and carboxy-terminal regions outside of the B/HLH/LZ motif partly separated these activities, suggesting various modes of Max regulation. We demonstrate that the Max protein is a nuclear protein in vivo and identify a carboxy-terminal region similar to nuclear localization signals whose integrity is necessary for efficient localization. Two mutants that delete amino- or carboxy-terminal consensus signals for casein kinase II (CKII) exhibited altered gel mobility and DNA-binding potential in vitro and showed modified transforming potential in the Ras cotransformation assay, suggesting that CKII or a CKII-related enzyme may regulate Max function in vivo. Our data suggest that both the ratio of Myc/Max hetero-oligomers to Max homo-oligomers and Max-specific regulation can contribute to determining the biological activity of Myc in vivo.
This article has been cited by other articles:
![]() |
J. B. DuHadaway, D. Sakamuro, D. L. Ewert, and G. C. Prendergast Bin1 Mediates Apoptosis by c-Myc in Transformed Primary Cells Cancer Res., April 1, 2001; 61(7): 3151 - 3156. [Abstract] [Full Text] |
||||
![]() |
K. Ge, J. DuHadaway, W. Du, M. Herlyn, U. Rodeck, and G. C. Prendergast Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma PNAS, August 17, 1999; 96(17): 9689 - 9694. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bahram, S. Wu, F. Oberg, B. Luscher, and L.-G. Larsson Posttranslational Regulation of Myc Function in Response to Phorbol Ester/Interferon-gamma -Induced Differentiation of v-Myc-Transformed U-937 Monoblasts Blood, June 1, 1999; 93(11): 3900 - 3912. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Facchini and L. Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J, June 1, 1998; 12(9): 633 - 651. [Abstract] [Full Text] |
||||
![]() |
X. Weihua, D. J. Lindner, and D. V. Kalvakolanu The interferon-inducible murine p48 (ISGF3gamma ) gene is regulated by protooncogene c-myc PNAS, July 8, 1997; 94(14): 7227 - 7232. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Desbarats, S Gaubatz, and M Eilers Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc. Genes & Dev., February 15, 1996; 10(4): 447 - 460. [Abstract] [PDF] |
||||
![]() |
D E Ayer and R N Eisenman A switch from Myc:Max to Mad:Max heterocomplexes accompanies monocyte/macrophage differentiation. Genes & Dev., November 1, 1993; 7(11): 2110 - 2119. [Abstract] [PDF] |
||||
![]() |
C. Moens, B. Stanton, L. Parada, and J Rossant Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus Development, January 10, 1993; 119(2): 485 - 499. [Abstract] [PDF] |
||||